ARCB vs IONS · P/E 11, rev $4.18B vs rev $226.6M
ArcBest Corp (ARCB) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
ArcBest Corp (ARCB) is a trucking company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ARCB revenue for 2024-12-31 was $4.18B. Net income was $174.0M. Revenue was down 5.6% from 2023-12-31 to 2024-12-31. ARCB currently screens at market cap $1.94B and trailing P/E 11.2.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
ARCB currently screens at market cap $1.94B and trailing P/E 11.2. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ARCB and IONS stock pages for the full models.
Not investment advice.